Related Videos
Video
SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer
Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.
Video
2025 SABCS Highlights: Advances in ctDNA for Breast Cancer
Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in ctDNA and minimal residual disease (MRD) for breast cancer in the neoadjuvant, adjuvant, and advance settings. This research was presented at the 2025 San ...
Video
2025 San Antonio Breast Cancer Symposium Recap
Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.
Video
SABCS Highlights: Advances in Oral SERD's for Breast Cancer
Harold Burstein, MD, PhD, and Rinath M. Jeselsohn, MD, discuss the lidERA, evERA, and EMBER-3 trials researching oral selective estrogen receptor degraders (SERDs).
Video
2025 SABCS Highlights: Advances in ADC's for Advanced Breast Cancer
Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD, discuss the ASCENT-04, ASCENT-03, TROPION-Breast02, ASCENT-07, and OptiTROP-Breast02 trials researching antibody-drug conjugates (ADCs) for breast cancer.
Video
2025 San Antonio Breast Cancer Symposium Highlights
Harold Burstein, MD, PhD, and other breast cancer experts at Dana-Farber discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.
Video
2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for first-line treatment in advanced breast cancer, which were presented at the 2025 San Antonio Breast Cancer Symposium.
Video
2025 San Antonio Breast Cancer Symposium Panel Discussion
Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and Elizabeth Ann Mittendorf, MD, PhD, MHCM, discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.
Video
SABCS 2025 Highlights: Patient Perspective
Lindsay Northrop, breast cancer survivor and patient advocate at Dana-Farber, talks with Harold Burstein, MD, PhD, about how recent advances in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium will impact patient care.